Platelets are used to prevent or treat bleeding in patients undergoing chemotherapy for cancer, after major trauma, or or after surgery, and in individuals who do not produce. INTERSOL solution has no therapeutic effect by themselves, but nutrients nutrients and an appropriate environment for the platelets provide. ‘The approval of INTERSOL a major step in the development and commercialization of novel method for the storage of platelets,’said Karen Midthun, deputy director of the FDA Center for Biologics Evaluation and Research.
Fertility treatment has to depend on the woman pulmonary and nutritional status, and there are ethical concerns about the welfare of the child whose mother might very ill, have a lung transplants transplants or die. .. To examine in the first, long-running study and evaluate systematically the use of assisted reproductive techniques in a group of infertile women with CF, researchers at H Pital Cochin, Saint Vincent de Paul in Paris looked at 24 women between 1998 and 2008. Were normal. Their health, three women have been undergoing fertility treatment for medical reasons and recommended six is still under investigation.Show Phase 2 combination of the combination of entinostat and erlotinib effectively in treatment of NSCLC in patients with increased levels of molecular cancer marker than E-cadherin to erlotinib alone. University of Colorado Cancer Center researchers, which faculty of the University of Colorado School of Medicine have had the first the first, elevated E-cadherin as targetable cancer markers, said first, the biomarkers cancer the test process for elevated E-cadherin and the development of first that be tested combined therapy..
About 60 % of patients with advanced NSCLC which means it has spread over the lungs, when they are seen by a doctor. Which five-year survival rate less than 10 %age of patients with advanced NSCLC.. may select with a biomarker of patients based on the Tumour Biology enhance treatment results compared with the treatment of a selected patient population, the University of Colorado Cancer Center researcher Fred Hirsch Professor of medical oncology, wrote to the CU Medical School in. – information from the Phase 2 clinical trial by Harry jotte, of Rocky Mountain Cancer Center, hotels in Denver out, was presented to to the ASTRO 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology, by the American Society for Radiation Oncology co-sponsor, the American Society for Clinical Oncology, more than 200 for the Study of of lung cancer and the University of Chicago.